LLY
LLY
US5324571083
Eli Lilly and Company
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 70/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)
0.45x
Defensive
Volatility (5Y p.a.)
32.7% p.a.
5-Year Horizon
Max Drawdown (5Y)
-34.8%
5-Year Horizon
Sharpe Ratio
1.09
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +38.3%
3 Years 35.5% -34.8% 0.69 +26.9%
5 Years 32.7% -34.8% 1.09 +38%
10 Years 30.6% -34.8% 0.91 +30.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.7% p.a.).

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
8 ISS Score: 8 / 10
Board Risk
5 ISS Score: 5 / 10
Short Ratio
3.09
ende